Thomas Weiser

3.0k total citations
76 papers, 2.3k citations indexed

About

Thomas Weiser is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Pharmacology. According to data from OpenAlex, Thomas Weiser has authored 76 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Molecular Biology, 24 papers in Cellular and Molecular Neuroscience and 20 papers in Pharmacology. Recurrent topics in Thomas Weiser's work include Ion channel regulation and function (19 papers), Neuroscience and Neuropharmacology Research (17 papers) and Pain Mechanisms and Treatments (14 papers). Thomas Weiser is often cited by papers focused on Ion channel regulation and function (19 papers), Neuroscience and Neuropharmacology Research (17 papers) and Pain Mechanisms and Treatments (14 papers). Thomas Weiser collaborates with scholars based in Germany, Switzerland and United States. Thomas Weiser's co-authors include Max Gassmann, Ulrich Hübscher, Pia Thömmes, Thomas P. Singer, M. Wienrich, Franziska Boess, Adrian Roth, Laura Suter‐Dick, Friedrich‐Wilhelm Bentrup and Nicola Wilson and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Neuroscience.

In The Last Decade

Thomas Weiser

73 papers receiving 2.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Thomas Weiser Germany 26 1.1k 476 325 204 192 76 2.3k
Jun Yao China 27 1.3k 1.2× 288 0.6× 272 0.8× 171 0.8× 117 0.6× 189 2.5k
Xiaohong Zhou China 35 1.8k 1.6× 566 1.2× 286 0.9× 159 0.8× 95 0.5× 162 4.2k
Patrick Emond France 37 1.7k 1.5× 898 1.9× 375 1.2× 153 0.8× 232 1.2× 165 4.0k
Roger J. Bick United States 30 1.4k 1.3× 265 0.6× 668 2.1× 379 1.9× 135 0.7× 84 3.4k
Ralph Laufer Italy 27 1.1k 1.0× 460 1.0× 372 1.1× 87 0.4× 94 0.5× 61 2.8k
S. Yamamoto Japan 32 1.3k 1.2× 495 1.0× 235 0.7× 135 0.7× 125 0.7× 121 3.0k
Ji‐Min Cao China 25 1.1k 1.0× 291 0.6× 197 0.6× 213 1.0× 71 0.4× 86 2.9k
Kazuto Yamazaki Japan 35 2.0k 1.8× 862 1.8× 455 1.4× 196 1.0× 153 0.8× 123 4.3k
Yafang Zhang China 34 1.4k 1.3× 325 0.7× 233 0.7× 95 0.5× 142 0.7× 165 3.6k

Countries citing papers authored by Thomas Weiser

Since Specialization
Citations

This map shows the geographic impact of Thomas Weiser's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Weiser with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Weiser more than expected).

Fields of papers citing papers by Thomas Weiser

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Weiser. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Weiser. The network helps show where Thomas Weiser may publish in the future.

Co-authorship network of co-authors of Thomas Weiser

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Weiser. A scholar is included among the top collaborators of Thomas Weiser based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Weiser. Thomas Weiser is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Predel, Hans‐Georg, Caty Ebel‐Bitoun, Barbara Peil, Thomas Weiser, & Robert Lange. (2020). Efficacy and Safety of Diclofenac + Capsaicin Gel in Patients with Acute Back/Neck Pain: A Multicenter Randomized Controlled Study. SHILAP Revista de lepidopterología. 9(1). 279–296. 13 indexed citations
2.
3.
Ebel‐Bitoun, Caty, et al.. (2019). A randomized, placebo- and active-controlled, multi-country, multi-center parallel group trial to evaluate the efficacy and safety of a fixed-dose combination of 400 mg ibuprofen and 100 mg caffeine compared with ibuprofen 400 mg and placebo in patients with acute lower back or neck pain. SHILAP Revista de lepidopterología.
4.
5.
6.
Kern, Kai‐Uwe & Thomas Weiser. (2015). Topical ambroxol for the treatment of neuropathic pain. Der Schmerz. 29(S3). 89–96. 20 indexed citations
7.
Bessa, Juliana, Sabine Boeckle, Hermann Beck, et al.. (2015). The Immunogenicity of Antibody Aggregates in a Novel Transgenic Mouse Model. Pharmaceutical Research. 32(7). 2344–2359. 101 indexed citations
8.
Babiarz, Joshua, Sriram Sridhar, Palanikumar Ravindran, et al.. (2011). Determination of the Human Cardiomyocyte mRNA and miRNA Differentiation Network by Fine-Scale Profiling. Stem Cells and Development. 21(11). 1956–1965. 80 indexed citations
9.
Weiser, Thomas. (2008). Ambroxol: A CNS Drug?. CNS Neuroscience & Therapeutics. 14(1). 17–24. 35 indexed citations
10.
Gaida, Wolfram, Klaus Klinder, Kirsten Arndt, & Thomas Weiser. (2005). Ambroxol, a Nav1.8-preferring Na+ channel blocker, effectively suppresses pain symptoms in animal models of chronic, neuropathic and inflammatory pain. Neuropharmacology. 49(8). 1220–1227. 75 indexed citations
11.
Ruepp, Stefan, Franziska Boess, G Steiner, et al.. (2005). Assessment of hepatotoxic liabilities by transcript profiling. Toxicology and Applied Pharmacology. 207(2). 161–170. 28 indexed citations
12.
Weiser, Thomas & Nicola Wilson. (2002). Inhibition of Tetrodotoxin (TTX)-Resistant and TTX-Sensitive Neuronal Na+ Channels by the Secretolytic Ambroxol. Molecular Pharmacology. 62(3). 433–438. 57 indexed citations
13.
Weiser, Thomas. (2002). AMPA Receptor Antagonists with Additional Mechanisms of Action: New Opportunities for Neuroprotective Drugs?. Current Pharmaceutical Design. 8(10). 941–951. 13 indexed citations
14.
Weiser, Thomas, et al.. (2001). The AMPA receptor/Na+ channel blocker BIIR 561 CL is protective in a model of global cerebral ischaemia. European Journal of Pharmacology. 421(3). 165–170. 4 indexed citations
15.
Seifert, Gerald, Min Zhou, Dirk Dietrich, et al.. (2000). Developmental regulation of AMPA-receptor properties in CA1 pyramidal neurons of rat hippocampus. Neuropharmacology. 39(6). 931–942. 25 indexed citations
16.
Weiser, Thomas, H. Wieland, & Henri Doods. (2000). Effects of the neuropeptide Y Y2 receptor antagonist BIIE0246 on presynaptic inhibition by neuropeptide Y in rat hippocampal slices. European Journal of Pharmacology. 404(1-2). 133–136. 35 indexed citations
17.
Weiser, Thomas, Michael Brenner, Angelo Ceci, et al.. (1999). BIIR 561 CL: A Novel Combined Antagonist of α-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid Receptors and Voltage-Dependent Sodium Channels with Anticonvulsive and Neuroprotective Properties. Journal of Pharmacology and Experimental Therapeutics. 289(3). 1343–1349. 8 indexed citations
18.
19.
Reifarth, F., Thomas Weiser, & Friedrich‐Wilhelm Bentrup. (1994). Voltage- and Ca2+-dependence of the K+ channel in the vacuolar membrane of Chenopodium rubrum L. suspension cells. Biochimica et Biophysica Acta (BBA) - Biomembranes. 1192(1). 79–87. 20 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jun Yao Breakdown of academic impact, for papers by Xiaohong Zhou Breakdown of academic impact, for papers by Patrick Emond Breakdown of academic impact, for papers by Roger J. Bick Breakdown of academic impact, for papers by Ralph Laufer Breakdown of academic impact, for papers by S. Yamamoto Breakdown of academic impact, for papers by Ji‐Min Cao Breakdown of academic impact, for papers by Kazuto Yamazaki Breakdown of academic impact, for papers by Yafang Zhang
Rankless by CCL
2026